Unknown

Dataset Information

0

Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts.


ABSTRACT: BACKGROUND:Although caffeine and glucocorticoids are frequently used to treat chronic lung disease in preterm neonates, potential interactions are largely unknown. While anti-inflammatory effects of glucocorticoids are well defined, their impact on airway remodeling is less characterized. Caffeine has been ascribed to positive effects on airway inflammation as well as remodeling. Connective tissue growth factor (CTGF, CCN2) plays a key role in airway remodeling and has been implicated in the pathogenesis of chronic lung diseases such as bronchopulmonary dysplasia (BPD) in preterm infants. The current study addressed the impact of glucocorticoids on the regulation of CTGF in the presence of caffeine using human lung epithelial and fibroblast cells. METHODS:The human airway epithelial cell line H441 and the fetal lung fibroblast strain IMR-90 were exposed to different glucocorticoids (dexamethasone, budesonide, betamethasone, prednisolone, hydrocortisone) and caffeine. mRNA and protein expression of CTGF, TGF-?1-3, and TNF-? were determined by means of quantitative real-time PCR and immunoblotting. H441 cells were additionally treated with cAMP, the adenylyl cyclase activator forskolin, and the selective phosphodiesterase (PDE)-4 inhibitor cilomilast to mimic caffeine-mediated PDE inhibition. RESULTS:Treatment with different glucocorticoids (1 ?M) significantly increased CTGF mRNA levels in H441 (p?

SUBMITTER: Fehrholz M 

PROVIDER: S-EPMC5363056 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts.

Fehrholz Markus M   Glaser Kirsten K   Speer Christian P CP   Seidenspinner Silvia S   Ottensmeier Barbara B   Kunzmann Steffen S  

Respiratory research 20170323 1


<h4>Background</h4>Although caffeine and glucocorticoids are frequently used to treat chronic lung disease in preterm neonates, potential interactions are largely unknown. While anti-inflammatory effects of glucocorticoids are well defined, their impact on airway remodeling is less characterized. Caffeine has been ascribed to positive effects on airway inflammation as well as remodeling. Connective tissue growth factor (CTGF, CCN2) plays a key role in airway remodeling and has been implicated in  ...[more]

Similar Datasets

| S-EPMC2901557 | biostudies-literature
| S-EPMC6086851 | biostudies-literature
| S-EPMC4020861 | biostudies-literature
| S-EPMC7731197 | biostudies-literature
| S-EPMC4429058 | biostudies-literature
| S-EPMC2753790 | biostudies-literature
| S-EPMC3529382 | biostudies-literature
| S-EPMC4783067 | biostudies-literature
| S-EPMC6917034 | biostudies-literature
| S-EPMC6588580 | biostudies-literature